Enanta Pharmaceuticals (ENTA) EBITDA Margin (2012 - 2026)
Enanta Pharmaceuticals (ENTA) reported EBITDA Margin of -111.78% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 15.23 percentage points from -96.55% a year earlier and down 49.76 percentage points from the prior quarter.
Enanta Pharmaceuticals (ENTA) EBITDA Margin (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enanta Pharmaceuticals' EBITDA Margin came in at -82.47%, up 61.09 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at -123.63%, up 52.83 percentage points from FY2024.
- EBITDA Margin has a five-year change of -92.61 percentage points (FY2020 to FY2025).
- By fiscal year, EBITDA Margin came in at -176.47% in FY2024 (-6.23 pp), -170.24% in FY2023 (-29.95 pp), -140.29% in FY2022 (-30.85 pp) and -109.44% in FY2021 (-78.42 pp).
- Five-year quarterly EBITDA Margin spans a low of -218.66% in fiscal Q2 2023 and a high of -53.84% in fiscal Q1 2026.
- Year over year, EBITDA Margin gained in six of the last eight quarters, with an average year-over-year change of +41.20 percentage points.
- The high point for year-over-year EBITDA Margin in five years was fiscal Q2 2026 (a gain of 94.24 percentage points); the low point was fiscal Q1 2022 (a drop of 71.16 percentage points).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -62.03% (Q2 2026), -53.84% (Q1 2026) and -113.07% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - | -111.78% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -111.78% |
| Mar 31, 2026 | -62.03% |
| Dec 31, 2025 | -53.84% |
| Sep 30, 2025 | -113.07% |
| Jun 30, 2025 | -96.55% |
| Mar 31, 2025 | -156.26% |
| Dec 31, 2024 | -133.58% |
| Sep 30, 2024 | -201.10% |
| Jun 30, 2024 | -131.27% |
| Mar 31, 2024 | -188.49% |
| Dec 31, 2023 | -190.21% |
| Sep 30, 2023 | -160.37% |
| Jun 30, 2023 | -190.89% |
| Mar 31, 2023 | -218.66% |
| Dec 31, 2022 | -125.09% |
| Sep 30, 2022 | -129.91% |
| Jun 30, 2022 | -163.38% |
| Mar 31, 2022 | -176.45% |
| Dec 31, 2021 | -107.17% |
| Sep 30, 2021 | -139.64% |
Enanta Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();